APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buclizine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Buclizine Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchBuclizine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Buclizine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Buclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buclizine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Buclizine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Buclizine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Buclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Buclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Buclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Buclizine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Buclizine include Sanofi, Johnson and Johnson, Pfizer, UCB, Stuart Pharmaceuticals, Sinphar, Peili Pharmaceutical, MK Pharma and Meider Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Buclizine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Buclizine, also provides the sales of main regions and countries. Of the upcoming market potential for Buclizine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Buclizine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Buclizine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Buclizine sales, projected growth trends, production technology, application and end-user industry.

Buclizine Segment by Company

Sanofi

Johnson and Johnson

Pfizer

UCB

Stuart Pharmaceuticals

Sinphar

Peili Pharmaceutical

MK Pharma

Meider Pharma

Mankind Pharma

Laboratorios Rocnarf

HUA Shin Chemical Pharmaceutical

Al Pharm

Buclizine Segment by Type

Hospital

Drug Store

Buclizine Segment by Application

Antiallergic Agent

Histamine H₁-Receptor Antagonist

Buclizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buclizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buclizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buclizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Buclizine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Buclizine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Buclizine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Buclizine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hospital Major Manufacturers Table 3. Drug Store Major Manufacturers Table 4. Global Buclizine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Antiallergic Agent Major Manufacturers Table 6. Histamine H₁-Receptor Antagonist Major Manufacturers Table 7. Buclizine Industry Trends Table 8. Buclizine Industry Drivers Table 9. Buclizine Industry Opportunities and Challenges Table 10. Buclizine Industry Restraints Table 11. Global Buclizine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Buclizine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Buclizine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Buclizine Revenue Market Share by Region (2021-2026) Table 15. Global Buclizine Revenue Market Share by Region (2027-2032) Table 16. Global Buclizine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Buclizine Sales by Region (2021-2026) & (K Units) Table 18. Global Buclizine Sales by Region (2027-2032) & (K Units) Table 19. Global Buclizine Sales Market Share by Region (2021-2026) Table 20. Global Buclizine Sales Market Share by Region (2027-2032) Table 21. Global Buclizine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Buclizine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Buclizine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Buclizine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Buclizine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Buclizine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Buclizine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Buclizine Manufacturers, Product Type & Application Table 29. Global Buclizine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Buclizine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Buclizine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Buclizine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Buclizine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Buclizine Revenue Market Share by Type (2021-2026) Table 36. Global Buclizine Revenue Market Share by Type (2027-2032) Table 37. Global Buclizine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Buclizine Sales by Type (2021-2026) & (K Units) Table 39. Global Buclizine Sales by Type (2027-2032) & (K Units) Table 40. Global Buclizine Sales Market Share by Type (2021-2026) Table 41. Global Buclizine Sales Market Share by Type (2027-2032) Table 42. Global Buclizine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Buclizine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Buclizine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Buclizine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Buclizine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Buclizine Revenue Market Share by Application (2021-2026) Table 48. Global Buclizine Revenue Market Share by Application (2027-2032) Table 49. Global Buclizine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Buclizine Sales by Application (2021-2026) & (K Units) Table 51. Global Buclizine Sales by Application (2027-2032) & (K Units) Table 52. Global Buclizine Sales Market Share by Application (2021-2026) Table 53. Global Buclizine Sales Market Share by Application (2027-2032) Table 54. Global Buclizine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Buclizine Price by Application (2027-2032) & (US$/Unit) Table 56. Sanofi Company Information Table 57. Sanofi Business Overview Table 58. Sanofi Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Sanofi Buclizine Product Portfolio Table 60. Sanofi Recent Development Table 61. Johnson and Johnson Company Information Table 62. Johnson and Johnson Business Overview Table 63. Johnson and Johnson Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Johnson and Johnson Buclizine Product Portfolio Table 65. Johnson and Johnson Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Pfizer Buclizine Product Portfolio Table 70. Pfizer Recent Development Table 71. UCB Company Information Table 72. UCB Business Overview Table 73. UCB Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. UCB Buclizine Product Portfolio Table 75. UCB Recent Development Table 76. Stuart Pharmaceuticals Company Information Table 77. Stuart Pharmaceuticals Business Overview Table 78. Stuart Pharmaceuticals Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Stuart Pharmaceuticals Buclizine Product Portfolio Table 80. Stuart Pharmaceuticals Recent Development Table 81. Sinphar Company Information Table 82. Sinphar Business Overview Table 83. Sinphar Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sinphar Buclizine Product Portfolio Table 85. Sinphar Recent Development Table 86. Peili Pharmaceutical Company Information Table 87. Peili Pharmaceutical Business Overview Table 88. Peili Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Peili Pharmaceutical Buclizine Product Portfolio Table 90. Peili Pharmaceutical Recent Development Table 91. MK Pharma Company Information Table 92. MK Pharma Business Overview Table 93. MK Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. MK Pharma Buclizine Product Portfolio Table 95. MK Pharma Recent Development Table 96. Meider Pharma Company Information Table 97. Meider Pharma Business Overview Table 98. Meider Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Meider Pharma Buclizine Product Portfolio Table 100. Meider Pharma Recent Development Table 101. Mankind Pharma Company Information Table 102. Mankind Pharma Business Overview Table 103. Mankind Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Mankind Pharma Buclizine Product Portfolio Table 105. Mankind Pharma Recent Development Table 106. Laboratorios Rocnarf Company Information Table 107. Laboratorios Rocnarf Business Overview Table 108. Laboratorios Rocnarf Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Laboratorios Rocnarf Buclizine Product Portfolio Table 110. Laboratorios Rocnarf Recent Development Table 111. HUA Shin Chemical Pharmaceutical Company Information Table 112. HUA Shin Chemical Pharmaceutical Business Overview Table 113. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio Table 115. HUA Shin Chemical Pharmaceutical Recent Development Table 116. Al Pharm Company Information Table 117. Al Pharm Business Overview Table 118. Al Pharm Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Al Pharm Buclizine Product Portfolio Table 120. Al Pharm Recent Development Table 121. North America Buclizine Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Buclizine Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Buclizine Sales by Type (2021-2026) & (K Units) Table 124. North America Buclizine Sales by Type (2027-2032) & (K Units) Table 125. North America Buclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 126. North America Buclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 127. North America Buclizine Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Buclizine Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Buclizine Sales by Application (2021-2026) & (K Units) Table 130. North America Buclizine Sales by Application (2027-2032) & (K Units) Table 131. North America Buclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 132. North America Buclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 133. North America Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Buclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. North America Buclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. North America Buclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. North America Buclizine Sales by Country (2021-2026) & (K Units) Table 138. North America Buclizine Sales by Country (2027-2032) & (K Units) Table 139. North America Buclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 140. North America Buclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 141. United States Buclizine Revenue (2021-2032) & (US$ Million) Table 142. Canada Buclizine Revenue (2021-2032) & (US$ Million) Table 143. Europe Buclizine Revenue by Type (2021-2026) & (US$ Million) Table 144. Europe Buclizine Revenue by Type (2027-2032) & (US$ Million) Table 145. Europe Buclizine Sales by Type (2021-2026) & (K Units) Table 146. Europe Buclizine Sales by Type (2027-2032) & (K Units) Table 147. Europe Buclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Europe Buclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Europe Buclizine Revenue by Application (2021-2026) & (US$ Million) Table 150. Europe Buclizine Revenue by Application (2027-2032) & (US$ Million) Table 151. Europe Buclizine Sales by Application (2021-2026) & (K Units) Table 152. Europe Buclizine Sales by Application (2027-2032) & (K Units) Table 153. Europe Buclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Europe Buclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Europe Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Europe Buclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Europe Buclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Europe Buclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Europe Buclizine Sales by Country (2021-2026) & (K Units) Table 160. Europe Buclizine Sales by Country (2027-2032) & (K Units) Table 161. Europe Buclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Europe Buclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Germany Buclizine Revenue (2021-2032) & (US$ Million) Table 164. France Buclizine Revenue (2021-2032) & (US$ Million) Table 165. U.K. Buclizine Revenue (2021-2032) & (US$ Million) Table 166. Italy Buclizine Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Buclizine Revenue (2021-2032) & (US$ Million) Table 168. China Buclizine Revenue by Type (2021-2026) & (US$ Million) Table 169. China Buclizine Revenue by Type (2027-2032) & (US$ Million) Table 170. China Buclizine Sales by Type (2021-2026) & (K Units) Table 171. China Buclizine Sales by Type (2027-2032) & (K Units) Table 172. China Buclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 173. China Buclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 174. China Buclizine Revenue by Application (2021-2026) & (US$ Million) Table 175. China Buclizine Revenue by Application (2027-2032) & (US$ Million) Table 176. China Buclizine Sales by Application (2021-2026) & (K Units) Table 177. China Buclizine Sales by Application (2027-2032) & (K Units) Table 178. China Buclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 179. China Buclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Buclizine Revenue by Type (2021-2026) & (US$ Million) Table 181. Asia Buclizine Revenue by Type (2027-2032) & (US$ Million) Table 182. Asia Buclizine Sales by Type (2021-2026) & (K Units) Table 183. Asia Buclizine Sales by Type (2027-2032) & (K Units) Table 184. Asia Buclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 185. Asia Buclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 186. Asia Buclizine Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Buclizine Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Buclizine Sales by Application (2021-2026) & (K Units) Table 189. Asia Buclizine Sales by Application (2027-2032) & (K Units) Table 190. Asia Buclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 191. Asia Buclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Asia Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Buclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Asia Buclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Asia Buclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 196. Asia Buclizine Sales by Country (2021-2026) & (K Units) Table 197. Asia Buclizine Sales by Country (2027-2032) & (K Units) Table 198. Asia Buclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 199. Asia Buclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 200. Japan Buclizine Revenue (2021-2032) & (US$ Million) Table 201. South Korea Buclizine Revenue (2021-2032) & (US$ Million) Table 202. India Buclizine Revenue (2021-2032) & (US$ Million) Table 203. Australia Buclizine Revenue (2021-2032) & (US$ Million) Table 204. China Taiwan Buclizine Revenue (2021-2032) & (US$ Million) Table 205. Southeast Asia Buclizine Revenue (2021-2032) & (US$ Million) Table 206. SAMEA Buclizine Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Buclizine Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Buclizine Sales by Type (2021-2026) & (K Units) Table 209. SAMEA Buclizine Sales by Type (2027-2032) & (K Units) Table 210. SAMEA Buclizine Sales Price by Type (2021-2026) & (US$/Unit) Table 211. SAMEA Buclizine Sales Price by Type (2027-2032) & (US$/Unit) Table 212. SAMEA Buclizine Revenue by Application (2021-2026) & (US$ Million) Table 213. SAMEA Buclizine Revenue by Application (2027-2032) & (US$ Million) Table 214. SAMEA Buclizine Sales by Application (2021-2026) & (K Units) Table 215. SAMEA Buclizine Sales by Application (2027-2032) & (K Units) Table 216. SAMEA Buclizine Sales Price by Application (2021-2026) & (US$/Unit) Table 217. SAMEA Buclizine Sales Price by Application (2027-2032) & (US$/Unit) Table 218. SAMEA Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Buclizine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. SAMEA Buclizine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. SAMEA Buclizine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. SAMEA Buclizine Sales by Country (2021-2026) & (K Units) Table 223. SAMEA Buclizine Sales by Country (2027-2032) & (K Units) Table 224. SAMEA Buclizine Sales Price by Country (2021-2026) & (US$/Unit) Table 225. SAMEA Buclizine Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Brazil Buclizine Revenue (2021-2032) & (US$ Million) Table 227. Argentina Buclizine Revenue (2021-2032) & (US$ Million) Table 228. Chile Buclizine Revenue (2021-2032) & (US$ Million) Table 229. Colombia Buclizine Revenue (2021-2032) & (US$ Million) Table 230. Peru Buclizine Revenue (2021-2032) & (US$ Million) Table 231. Saudi Arabia Buclizine Revenue (2021-2032) & (US$ Million) Table 232. Israel Buclizine Revenue (2021-2032) & (US$ Million) Table 233. UAE Buclizine Revenue (2021-2032) & (US$ Million) Table 234. Turkey Buclizine Revenue (2021-2032) & (US$ Million) Table 235. Iran Buclizine Revenue (2021-2032) & (US$ Million) Table 236. Egypt Buclizine Revenue (2021-2032) & (US$ Million) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Buclizine Distributors List Table 240. Buclizine Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Buclizine Image Figure 2. Global Buclizine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buclizine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hospital Image Figure 5. Drug Store Image Figure 6. Global Buclizine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Buclizine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Antiallergic Agent Image Figure 9. Histamine H₁-Receptor Antagonist Image Figure 10. Global Buclizine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Buclizine Revenue (2021-2032) & (US$ Million) Figure 12. Global Buclizine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Buclizine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Buclizine Revenue Market Share by Region (2021-2032) Figure 15. Global Buclizine Sales (2021-2032) & (K Units) Figure 16. Global Buclizine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Buclizine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Buclizine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Buclizine Sales YoY (2021-2032) & (K Units) Figure 20. China Buclizine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Buclizine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Buclizine Sales YoY (2021-2032) & (K Units) Figure 23. Global Buclizine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Buclizine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Buclizine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Buclizine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Buclizine Revenue Market Share by Type (2021-2032) Figure 29. Global Buclizine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Buclizine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Buclizine Sales Market Share by Type (2021-2032) Figure 32. Global Buclizine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Buclizine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Buclizine Revenue Market Share by Application (2021-2032) Figure 35. Global Buclizine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Buclizine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Buclizine Sales Market Share by Application (2021-2032) Figure 38. North America Buclizine Revenue Share by Type (2021-2032) Figure 39. North America Buclizine Sales Share by Type (2021-2032) Figure 40. North America Buclizine Revenue Share by Application (2021-2032) Figure 41. North America Buclizine Sales Share by Application (2021-2032) Figure 42. North America Buclizine Revenue Share by Country (2021-2032) Figure 43. North America Buclizine Sales Share by Country (2021-2032) Figure 44. Europe Buclizine Revenue Share by Type (2021-2032) Figure 45. Europe Buclizine Sales Share by Type (2021-2032) Figure 46. Europe Buclizine Revenue Share by Application (2021-2032) Figure 47. Europe Buclizine Sales Share by Application (2021-2032) Figure 48. Europe Buclizine Revenue Share by Country (2021-2032) Figure 49. Europe Buclizine Sales Share by Country (2021-2032) Figure 50. China Buclizine Revenue Share by Type (2021-2032) Figure 51. China Buclizine Sales Share by Type (2021-2032) Figure 52. China Buclizine Revenue Share by Application (2021-2032) Figure 53. China Buclizine Sales Share by Application (2021-2032) Figure 54. Asia Buclizine Revenue Share by Type (2021-2032) Figure 55. Asia Buclizine Sales Share by Type (2021-2032) Figure 56. Asia Buclizine Revenue Share by Application (2021-2032) Figure 57. Asia Buclizine Sales Share by Application (2021-2032) Figure 58. Asia Buclizine Revenue Share by Country (2021-2032) Figure 59. Asia Buclizine Sales Share by Country (2021-2032) Figure 60. SAMEA Buclizine Revenue Share by Type (2021-2032) Figure 61. SAMEA Buclizine Sales Share by Type (2021-2032) Figure 62. SAMEA Buclizine Revenue Share by Application (2021-2032) Figure 63. SAMEA Buclizine Sales Share by Application (2021-2032) Figure 64. SAMEA Buclizine Revenue Share by Country (2021-2032) Figure 65. SAMEA Buclizine Sales Share by Country (2021-2032) Figure 66. Buclizine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Buclizine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital
  • Drug Store
Applications
  • Antiallergic Agent
  • Histamine H₁-Receptor Antagonist
Companies covered
  • Sanofi
  • Johnson and Johnson
  • Pfizer
  • UCB
  • Stuart Pharmaceuticals
  • Sinphar
  • Peili Pharmaceutical
  • MK Pharma
  • Meider Pharma
  • Mankind Pharma
  • Laboratorios Rocnarf
  • HUA Shin Chemical Pharmaceutical
  • Al Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Buclizine Market by Type
  3. 1.2.1 Global Buclizine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hospital
  5. 1.2.3 Drug Store
  6. 1.3 Buclizine Market by Application
  7. 1.3.1 Global Buclizine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Antiallergic Agent
  9. 1.3.3 Histamine H₁-Receptor Antagonist
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Buclizine Market Dynamics
  1. 2.1 Buclizine Industry Trends
  2. 2.2 Buclizine Industry Drivers
  3. 2.3 Buclizine Industry Opportunities and Challenges
  4. 2.4 Buclizine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Buclizine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Buclizine Revenue by Region
  3. 3.2.1 Global Buclizine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Buclizine Revenue by Region (2021-2026)
  5. 3.2.3 Global Buclizine Revenue by Region (2027-2032)
  6. 3.2.4 Global Buclizine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Buclizine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Buclizine Sales by Region
  9. 3.4.1 Global Buclizine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Buclizine Sales by Region (2021-2026)
  11. 3.4.3 Global Buclizine Sales by Region (2027-2032)
  12. 3.4.4 Global Buclizine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Buclizine Revenue by Manufacturers
  2. 4.1.1 Global Buclizine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Buclizine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Buclizine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Buclizine Sales by Manufacturers
  6. 4.2.1 Global Buclizine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Buclizine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Buclizine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Buclizine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Buclizine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Buclizine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Buclizine Manufacturers, Product Type & Application
  13. 4.7 Global Buclizine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Buclizine Market CR5 and HHI
  16. 4.8.2 2025 Buclizine Tier 1, Tier 2, and Tier 3
5 Buclizine Market by Type
  1. 5.1 Global Buclizine Revenue by Type
  2. 5.1.1 Global Buclizine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Buclizine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Buclizine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Buclizine Sales by Type
  6. 5.2.1 Global Buclizine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Buclizine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Buclizine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Buclizine Price by Type
6 Buclizine Market by Application
  1. 6.1 Global Buclizine Revenue by Application
  2. 6.1.1 Global Buclizine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Buclizine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Buclizine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Buclizine Sales by Application
  6. 6.2.1 Global Buclizine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Buclizine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Buclizine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Buclizine Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Buclizine Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson and Johnson
  8. 7.2.1 Johnson and Johnson Company Information
  9. 7.2.2 Johnson and Johnson Business Overview
  10. 7.2.3 Johnson and Johnson Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson and Johnson Buclizine Product Portfolio
  12. 7.2.5 Johnson and Johnson Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Buclizine Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 UCB
  20. 7.4.1 UCB Company Information
  21. 7.4.2 UCB Business Overview
  22. 7.4.3 UCB Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 UCB Buclizine Product Portfolio
  24. 7.4.5 UCB Recent Developments
  25. 7.5 Stuart Pharmaceuticals
  26. 7.5.1 Stuart Pharmaceuticals Company Information
  27. 7.5.2 Stuart Pharmaceuticals Business Overview
  28. 7.5.3 Stuart Pharmaceuticals Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Stuart Pharmaceuticals Buclizine Product Portfolio
  30. 7.5.5 Stuart Pharmaceuticals Recent Developments
  31. 7.6 Sinphar
  32. 7.6.1 Sinphar Company Information
  33. 7.6.2 Sinphar Business Overview
  34. 7.6.3 Sinphar Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sinphar Buclizine Product Portfolio
  36. 7.6.5 Sinphar Recent Developments
  37. 7.7 Peili Pharmaceutical
  38. 7.7.1 Peili Pharmaceutical Company Information
  39. 7.7.2 Peili Pharmaceutical Business Overview
  40. 7.7.3 Peili Pharmaceutical Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Peili Pharmaceutical Buclizine Product Portfolio
  42. 7.7.5 Peili Pharmaceutical Recent Developments
  43. 7.8 MK Pharma
  44. 7.8.1 MK Pharma Company Information
  45. 7.8.2 MK Pharma Business Overview
  46. 7.8.3 MK Pharma Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 MK Pharma Buclizine Product Portfolio
  48. 7.8.5 MK Pharma Recent Developments
  49. 7.9 Meider Pharma
  50. 7.9.1 Meider Pharma Company Information
  51. 7.9.2 Meider Pharma Business Overview
  52. 7.9.3 Meider Pharma Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Meider Pharma Buclizine Product Portfolio
  54. 7.9.5 Meider Pharma Recent Developments
  55. 7.10 Mankind Pharma
  56. 7.10.1 Mankind Pharma Company Information
  57. 7.10.2 Mankind Pharma Business Overview
  58. 7.10.3 Mankind Pharma Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mankind Pharma Buclizine Product Portfolio
  60. 7.10.5 Mankind Pharma Recent Developments
  61. 7.11 Laboratorios Rocnarf
  62. 7.11.1 Laboratorios Rocnarf Company Information
  63. 7.11.2 Laboratorios Rocnarf Business Overview
  64. 7.11.3 Laboratorios Rocnarf Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Laboratorios Rocnarf Buclizine Product Portfolio
  66. 7.11.5 Laboratorios Rocnarf Recent Developments
  67. 7.12 HUA Shin Chemical Pharmaceutical
  68. 7.12.1 HUA Shin Chemical Pharmaceutical Company Information
  69. 7.12.2 HUA Shin Chemical Pharmaceutical Business Overview
  70. 7.12.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 HUA Shin Chemical Pharmaceutical Buclizine Product Portfolio
  72. 7.12.5 HUA Shin Chemical Pharmaceutical Recent Developments
  73. 7.13 Al Pharm
  74. 7.13.1 Al Pharm Company Information
  75. 7.13.2 Al Pharm Business Overview
  76. 7.13.3 Al Pharm Buclizine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Al Pharm Buclizine Product Portfolio
  78. 7.13.5 Al Pharm Recent Developments
8 North America
  1. 8.1 North America Buclizine Market Size by Type
  2. 8.1.1 North America Buclizine Revenue by Type (2021-2032)
  3. 8.1.2 North America Buclizine Sales by Type (2021-2032)
  4. 8.1.3 North America Buclizine Price by Type (2021-2032)
  5. 8.2 North America Buclizine Market Size by Application
  6. 8.2.1 North America Buclizine Revenue by Application (2021-2032)
  7. 8.2.2 North America Buclizine Sales by Application (2021-2032)
  8. 8.2.3 North America Buclizine Price by Application (2021-2032)
  9. 8.3 North America Buclizine Market Size by Country
  10. 8.3.1 North America Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Buclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Buclizine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Buclizine Market Size by Type
  2. 9.1.1 Europe Buclizine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Buclizine Sales by Type (2021-2032)
  4. 9.1.3 Europe Buclizine Price by Type (2021-2032)
  5. 9.2 Europe Buclizine Market Size by Application
  6. 9.2.1 Europe Buclizine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Buclizine Sales by Application (2021-2032)
  8. 9.2.3 Europe Buclizine Price by Application (2021-2032)
  9. 9.3 Europe Buclizine Market Size by Country
  10. 9.3.1 Europe Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Buclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Buclizine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Buclizine Market Size by Type
  2. 10.1.1 China Buclizine Revenue by Type (2021-2032)
  3. 10.1.2 China Buclizine Sales by Type (2021-2032)
  4. 10.1.3 China Buclizine Price by Type (2021-2032)
  5. 10.2 China Buclizine Market Size by Application
  6. 10.2.1 China Buclizine Revenue by Application (2021-2032)
  7. 10.2.2 China Buclizine Sales by Application (2021-2032)
  8. 10.2.3 China Buclizine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Buclizine Market Size by Type
  2. 11.1.1 Asia Buclizine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Buclizine Sales by Type (2021-2032)
  4. 11.1.3 Asia Buclizine Price by Type (2021-2032)
  5. 11.2 Asia Buclizine Market Size by Application
  6. 11.2.1 Asia Buclizine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Buclizine Sales by Application (2021-2032)
  8. 11.2.3 Asia Buclizine Price by Application (2021-2032)
  9. 11.3 Asia Buclizine Market Size by Country
  10. 11.3.1 Asia Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Buclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Buclizine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Buclizine Market Size by Type
  2. 12.1.1 SAMEA Buclizine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Buclizine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Buclizine Price by Type (2021-2032)
  5. 12.2 SAMEA Buclizine Market Size by Application
  6. 12.2.1 SAMEA Buclizine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Buclizine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Buclizine Price by Application (2021-2032)
  9. 12.3 SAMEA Buclizine Market Size by Country
  10. 12.3.1 SAMEA Buclizine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Buclizine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Buclizine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Buclizine Value Chain Analysis
  2. 13.1.1 Buclizine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Buclizine Production Mode & Process
  6. 13.2 Buclizine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Buclizine Distributors
  9. 13.2.3 Buclizine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst